Halozyme Therapeutics, Inc.: Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team SAN ...
Piper Sandler Sticks to Its Buy Rating for Akebia Therapeutics (AKBA)
Piper Sandler analyst Allison Bratzel maintained a Buy rating on Akebia Therapeutics (AKBA – Research Report) today and set a price ...
SDxCentral11h
Halozyme Proposes €2 Billion Acquisition of Evotec at €11 Per Share
Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team Storage-Area Networking (SAN) DIEGO, ...
Halozyme Confirms Proposal To Combine With Evotec For €11.00 Per Share In An All-Cash Transaction
Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, ...
Idiopathic Membranous Nephropathy Market Size is estimated to grow with a significant CAGR during the study period (2020-2034).
Idiopathic Membranous Nephropathy Treatment Market is projected to witness substantial growth over the next few years, driven ...
Worldwide Healthcare Trust PLC - Half-year Report
LONDON STOCK EXCHANGE ANNOUNCEMENT ...
Zai Lab announces $200M American depositary shares offering
Limited announced that it has commenced an underwritten public offering of $200M of American depositary shares, ADSs, each ...
Rare Disease Thematic Intelligence Report 2024: Examine Healthcare, Macroeconomic, Technology, and Regulatory Impacts
The "Thematic Intelligence: Rare Disease" report has been added to ResearchAndMarkets.com's offering.In recent years, there has been growing recognition of the importance of rare diseases as a global ...
NDTV13h
World News
More than 40,000 Gen Z and millennial Bumble users worldwide, including over 2,000 singles in India, participated in the survey.